M
Mohanapriya Arumugam
Researcher at VIT University
Publications - 23
Citations - 149
Mohanapriya Arumugam is an academic researcher from VIT University. The author has contributed to research in topics: Psoriasis & Virtual screening. The author has an hindex of 7, co-authored 23 publications receiving 117 citations.
Papers
More filters
Journal ArticleDOI
Comorbidities of Psoriasis - Exploring the Links by Network Approach
TL;DR: The pathway analysis revealed the presence of few common pathways such as angiogenesis and few uncommon pathways which includes CCKR signaling map and gonadotrophin-realising hormone receptor pathway overlapping in all the comorbidities.
Journal ArticleDOI
Weighted gene co-expression based biomarker discovery for psoriasis detection.
TL;DR: WGCNA, the network based approach has provided an alternative path to mine out key controllers and drivers of psoriasis, and the study principle from the current work can be extended to other pathological conditions.
Journal ArticleDOI
A systems pharmacology perspective to decipher the mechanism of action of Parangichakkai chooranam, a Siddha formulation for the treatment of psoriasis.
TL;DR: The present work sheds light on the mechanism of action of PC in treating psoriasis and highlights the pharmacological action of the formulation but also emphasis on safe herbal remedies offered by the Siddha medicinal system.
Journal ArticleDOI
Insights into protein interaction networks reveal non-receptor kinases as significant druggable targets for psoriasis.
TL;DR: The computational approach has aided in the identification of non-receptor kinases as potential targets for psoriasis drug development.
Journal ArticleDOI
Computational evaluation of phytocompounds for combating drug resistant tuberculosis by multi-targeted therapy
TL;DR: Comparing structure based virtual screening with physicochemical and pharmacokinetic studies against rhamnose pathway enzymes identified potential leads and recognized butein, a secondary metabolite from Butea monosperma with strong anti-tubercular bioactive spectrum, which displayed promising anti-mycobacterial activity.